• 2018 Gastroenterology Conference, all presentations

    Original Date: October 20-21, 2018

    This discounted package includes all of the individual presentations from the conference.

    12.0 CEUs (10.0 general, 1.5 pharmacy, and 0.5 ethics) approved by OBNM
  • Non-Celiac Gluten Sensitivity

    Presenter: Lisa Shaver, ND, LAc
    Original Date: October 20, 2018

    In your practice, 6% of your patients, or more, have Non-Celiac Gluten Sensitivity (NCGS). Confused the difference between NCGS, non-celiac wheat sensitivity, gluten allergy, wheat food sensitivity, wheat allergy and celiac disease? Dr Shaver discusses diagnosis and reviews the research about this relatively new condition, named in 2011. There are important ethical issues to discuss with your patient prior to prescribing any of the current gluten-free diets (Keto, Paleo, Low Fodmap, Anti-Inflammatory, Wahls, etc.) if one has not thoroughly tested for NCGS and celiac disease.

    1.5 CEUs (0.5 ethics and 1.0 general) approved by OBNM
  • Gastrointestinal Infections: Considerations and Treatment

    Presenter: Anne Hill, ND
    Original Date: October 20, 2018

    This lecture discusses common gastrointestinal bacterial and parasitic infections and gives guidance for diagnosis and treatment. Also discussed is the importance of eradication of these infections as a key primary approach to reversing metabolic endotoxemia and establishing optimal gastrointentinal health. Prescriptive medications as well as herbal and nutraceutical treatments are discussed as well.

    Pharmaceuticals discussed include: Pyrantal Pamoate, Nitazoxanide, Praziquantel, Albendazole, Mebendazole, Tinidazole, Ivermectin, Iodoquinol

    1.5 CEUs (0.5 pharmacy and 1.0 general) approved by OBNM
  • Sterol Biome

    Presenter: Steven Sandberg-Lewis, ND
    Original Date: October 20, 2018

    The liver synthesizes and secretes hydrophilic primary bile acids, processed in the small and large bowel by the microbiota. These enter the enterohepatic circulation and join the bile acid pool. These bile acids are hormones that regulate their own synthesis and transport as well as regulating lipid, glucose, lipoprotein and energy metabolism as well as inflammation.

    Dr. Sandberg-Lewis reviews the biochemistry and physiology of these processes and discuss the use of botanicals, nutrition and prescription medication to aid the activity of this essential “endocrine organ”.

    1.5 general CEUs approved by OBNM
  • Research Updates in IBS

    Presenter: Joshua Goldenberg, ND
    Original Date: October 20, 2018

    This presentation reviews the latest update from the Bastyr research group and affiliated international naturopathic researchers focused on whole systems naturopathic approaches to irritable bowel syndrome (IBS).

    Specifically, one of only a few expert consensus panels on naturopathic medicine was completed recently - The Expert Consensus for Naturopathic Approaches to IBS. A shocking 42 items of consensus were agreed upon leading to a real possibility of an external valid randomized trial of Naturopathic Approaches to IBS in the future. Our progress on the largest international observational study of naturopathic medicine to-date (the IRCNAC-IBS study) and the consortium supporting it – the first ever, international research consortium of naturopathic academic clinics – will be reviewed. Additionally, we discuss findings from the first fully naturopathically designed and executed Cochrane Review – Biofeedback to Treat IBS.

    1.5 general CEUs approved by OBNM
  • “Gut Healing” Protocols

    Presenter: Ilana Gurevich, ND, LAc
    Original Date: October 21, 2018

    This presentation takes a look at the natural agents that are most studied to heal intestinal permeability. We discuss natural agents as well as pharmaceutical that are available for repair.

    Medications discussed include:
    • Linzess
    • Amitizia
    • Trulance
    • Resolor

    1.0 CEUs (0.5 pharmacy and 0.5 general) approved by OBNM
  • Assessing the Microbiome in Gastrointestinal Health

    Presenter: Mark Davis, ND
    Original Date: October 21, 2018

    Naturopathic doctors have always stressed the importance of treating the gut, and have used personalized diet to optimize health, botanical and other antimicrobials to treat stealth pathogens, and numerous other interventions to minimize harmful levels of inflammation and otherwise encourage best outcomes. How does the normal microbiome influence the importance and success of these treatments? How can emerging technology help us assess the importance of commensals and “possible pathogens?”

    1.0 general CEUs approved by OBNM
  • Updates in CRC Screening Guidelines

    Presenter: Eliot Edwards, ND, FABNO
    Original Date: October 21, 2018

    Colon cancer is the 3rd most common type of cancer in both men and women in the US. Naturopathic Physicians in a general medicine practice will inevitably see patients who have been diagnosed with colon cancer, or have a strong family history and thus risk factors for developing cancer. What is the role of the ND for these patients?

    Dr. Edwards provides an update on the most recent screening guidelines from the American Cancer Society which were changed in May 2018. Also a review of the more recent published research on integrative oncology for colon cancer is covered.

    0.5 general CEUs approved by OBNM
  • Cannabinoids as Mediators of GI Function

    Presenter: Jamie Corroon, ND, MPH
    Original Date: October 21, 2018

    The role of the endocannabinoid system in both physiological and pathophysiological function of the gastrointestinal tract is relatively unknown. Pharmacokinetic studies shed light on the metabolism and bioavailability of exogenous cannabinoids. Preclinical and clinical trials continue to explore the utility of using cannabinoids as therapeutic agents for gastrointestinal disorders. This presentation elucidates the key functions of the endocannabinoid system in maintaining gut function. It also summarizes existing evidence for using cannabinoids to treat GI disorders.

    Pharmaceuticals covered:
    • Cannabidiol
    • Nabiximols
    • Dronabinol
    • Nabilone

    1.0 general CEUs approved by OBNM
  • Treat the Gut: Approaching Pediatric Constipation

    Presenter: Caitlin O’Connor, ND
    Original Date: October 21, 2018

    Functional constipation is the most common reason for a GI referral in the pediatric population. Naturopathic medicine offers an extremely effective approach for treating these children that goes far beyond the routine laxative prescription. This presentation covers how to properly diagnose and treat constipation in this population and how to fill your toolkit with clinically applicable, evidence-based modalities that you can can immediately put into practice. This presentation also covers both pharmaceutical and non-pharmaceutical approaches to management. Polyethylene glycol, magnesium oxide and sennosides are reviewed.

    1.5 CEUs (0.5 pharmacy and 1.0 general) approved by OBNM
  • Visceral Hypersensitivity: Causes, Consequences, and Therapeutic Approaches

    Presenter: Megan Taylor, ND
    Original Date: October 21, 2018

    Visceral hypersensitivity occurs in up to a third of patients with IBS and Functional Dyspepsia, two of the most common functional gastrointestinal disorders presenting to naturopathic practices. This condition is often overlooked and rarely discussed in clinical context, yet can complicate presentation and often leaves patients with continued symptoms despite "normal" work-up. This presentation reviews the proposed causes of visceral hypersensitivity, its relationship to IBS and FGID, and various treatment approaches, including review of research on pharmaceutical, botanical, manual, and psychological interventions. Review of pharmaceuticals to include classes of SSRI, TCA, 5HT3 antagonists, 5HT4 agonists, GABAnergic agents, as well as Ketotifen & Naltrexone (low dose).

    1.0 general CEUs approved by OBNM

Privacy Policy